Modular Medical to Participate in the Association of Diabetes Care & Education Specialists 2026 Annual Conference
Rhea-AI Summary
Modular Medical (NASDAQ: MODD) will participate in the Association of Diabetes Care & Education Specialists 2026 Annual Conference in Columbus, Ohio, from August 7-10, 2026. Management will host booth #1516 to showcase live demonstrations of its Pivot™ tubeless insulin patch pump ahead of an October launch in five U.S. markets.
Positive
- None.
Negative
- None.
News Market Reaction – MODD
In the Aug 5 session, MODD declined 6.94%, reflecting a notable negative market reaction. Argus tracked a peak move of +3.9% during that session. Argus tracked a trough of -4.4% from its starting point during tracking. Our momentum scanner triggered 8 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jul 23 | Innovation council appointment | Positive | +2.7% | Formed Pivot Innovation Council and appointed Robert Gabbay as chairman |
| Jul 16 | Strategic pilot collaboration | Positive | -22.7% | Launched IMO Health pilot to identify potential pump candidates in electronic health records |
| Jul 15 | Payor research results | Positive | -2.8% | Reported positive payor receptivity toward Pivot reimbursement and partnership models |
| Jul 14 | Patient research results | Positive | +8.0% | Reported strong patient interest in simpler insulin pump therapy |
| Jul 01 | FDA submission | Positive | +4.0% | Submitted software enhancements for the Pivot tubeless insulin patch pump |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent positive announcements produced mixed reactions, with both aligned gains and substantial divergences.
Key Terms
tubeless patch pump medical
continuous subcutaneous insulin infusion medical
basal and bolus insulin delivery medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, CA / ACCESS Newswire / August 5, 2026 / Modular Medical, Inc ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial launch of its next-generation Pivot™ tubeless patch pump, today announced that management will host a booth at the Association of Diabetes Care & Education Specialists 2026 Annual Conference (the "Conference") in Columbus, Ohio, from August 7-10, 2026, where they will showcase the new Pivot tubeless insulin patch pump.
Conference attendees will have the opportunity to experience live demonstrations of the tubeless Pivot insulin pump and see firsthand how its intuitive, simplified design can expand access to insulin pump therapy. With one-button operation, tubeless freedom, and flexible wear that fits into everyday life, Pivot creates a compelling option for people who rely on daily insulin injections and may have never been offered pump therapy in the past. The Conference will provide an important opportunity for the team to engage diabetes care and education specialists, gather valuable feedback, and secure qualified leads, as they prepare for the October launch across five U.S. markets.
ADCES Conference Details:
Dates: August 7-10, 2026
Location: Greater Columbus Convention Center, Columbus, OH
Booth: #1516
To schedule a one-on-one meeting with Modular Medical's management team at the Conference, please email Patrick Pavlick at Patrick.pavlick@modular-medical.com or email KCSA Strategic Communications at ModularMedical@KCSA.com.
About the Pivot Tubeless Patch Pump
The Pivot™ tubeless patch pump is a simple, wearable insulin delivery platform designed to provide continuous subcutaneous insulin infusion with both basal and bolus insulin delivery over a three-day wear period. The system is intended to offer a practical and accessible pathway from multiple daily injections to insulin pump therapy for a broader population of people living with diabetes. For more information, visit www.pivotpump.com.
About Modular Medical, Inc.
Modular Medical, Inc. (NASDAQ:MODD) is a commercial-stage medical device company focused on the development of innovative insulin delivery technologies designed to simplify diabetes management and increase access to insulin pump therapy. The Company's Pivot™ tubeless patch pump has been developed to provide a user-friendly, flexible, and accessible approach to insulin delivery for people requiring intensive insulin therapy.
Forward-Looking Statements
This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statements contained in this press release, including but not limited to, the Company's ability to commence the commercial launch of its Pivot pump product across multiple U.S. markets in October 2026, successful development of Modular Medical's proprietary technologies, whether the market will accept Modular Medical's products and services, anticipated consumer demand for the Company's products, whether Modular Medical can successfully manufacture its products at high volumes, and general economic, and industry or political conditions in the United States or internationally, as well as other risk factors and business considerations described in Modular Medical's SEC filings, including its annual report on Form 10-K. Any forward-looking statements in this press release should be evaluated in light of these important risk factors. In addition, any forward-looking statements included in this press release represent Modular Medical's views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. Modular Medical assumes no obligation to update these forward-looking statements, except as required by law.
Pivot is a trademark of Modular Medical. All other trademarks mentioned herein are the property of their respective owners.
Company Contact:
Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
IR@modular-medical.com
Investor Relations Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
ModularMedical@KCSA.com
SOURCE: Modular Medical, Inc.
View the original press release on ACCESS Newswire